Deutsche Bank Aktiengesellschaft »

Rapport Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2025-12-31 $653k 22k 30.34
2025-09-30 $186k 6.2k 29.70
2025-06-30 $71k 6.2k 11.37
2025-03-31 $65k 6.5k 10.03
2024-12-31 $41k 2.3k 17.74